Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Both drugs : Share GLP-1 and glucagon receptor agonism, once-weekly subcutaneous dosing, similar GI side effect profiles, and investigational status
In clinical trials, treatment with tirzepatide produced superior weight loss and glycemic control compared to GLP-1RAs 3,17 , suggesting that agonism at both the GIPR and GLP-1R is beneficial in humans with type 2 diabetes
Novo Nordisks GLP-1, sold as Wegovy or Ozempic, and Eli Lillys tirzapetide, sold as Mounjaro, are relative newcomers to the market today
Contact Your Provider: Reach out to the clinical team through our platform to let them know
US$ 23.20
US$ 20.47
US$ 25.20
US$ 22.13
US$ 25.90
US$ 24.71
US$ 26.60
